Cargando…
CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis
BACKGROUND AND OBJECTIVES: Complement regulatory proteins at the neuromuscular junction (NMJ) could offer protection against complement-mediated damage in myasthenia gravis (MG). However, there is limited information on their expression at the human NMJ. Thus, this study aimed at investigating the e...
Autores principales: | Iwasa, Kazuo, Furukawa, Yutaka, Yoshikawa, Hiroaki, Yamada, Masahito, Ono, Kenjiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747141/ https://www.ncbi.nlm.nih.gov/pubmed/36396448 http://dx.doi.org/10.1212/NXI.0000000000200057 |
Ejemplares similares
-
Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018
por: Yoshikawa, Hiroaki, et al.
Publicado: (2022) -
Immunotherapy for ocular myasthenia gravis: an observational study in Japan
por: Narita, Tomoko, et al.
Publicado: (2023) -
Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020) -
Extraocular Muscle Atrophy in Myasthenia Gravis
por: Pedapati, Radhakrishna, et al.
Publicado: (2022) -
Relapsed Myasthenia Gravis after Nivolumab Treatment
por: Mitsune, Ayumi, et al.
Publicado: (2018)